Dr. Mohammad H. Kazemi

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Philosophy of care | Effective medical care begins with a deep understanding of each patient’s circumstances and needs. The physician-patient relationship is foundational and must be a two-way dialogue built on trust and respect. I prioritize learning what truly matters to you and your family. I offer treatment recommendations and options that align with your values, preferences and goals. While my clinical focus is on blood disorders and blood cancers, listening carefully and tailoring care to patients is the heart of everything I do. I provide guidance and recommendations, but the decisions ultimately belong to you, the patient. I strongly believe in a team-based approach, where collaboration and communication yield the best outcomes. | Why I entered medicine | When I started college, medicine was the farthest thing from my mind; I was an economics major and took the MCAT on a whim. To my surprise, I scored far better than expected for someone without a science background, and that led me to medical school. Looking back, I can’t imagine doing anything else. Medicine – and caring for patients – has become my true passion. My path into the field was unconventional but led me exactly where I was meant to be. Practicing hematology and oncology isn’t just a career for me – it’s the only thing I can see myself doing. | Community involvement | As a part of cancer center leadership, I participate in local events and charities for patients with cancer and blood diseases, including speaking to the leukemia/lymphoma society. I am particularly fond of events centered around running for cancer charities. | Personal interests | Running is a personal passion of mine – second only to medicine and my family. Dr. Lash is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

Jennifer Armstrong is an Oncologist and a Hematologist Oncology provider in Paoli, Pennsylvania. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Paris-Trousseau Thrombocytopenia, and RUNX1 Familial Platelet Disorder.